top of page

It's Time to Rethink Patient Engagement Strategy

Writer: Alyssa Prettyman
Alyssa Prettyman
Mar 29, 2022
1 min read

If the clinical trial industry is serious about promoting diversity, it's time to take a holistic approach to patient outreach and eschew its current "transactional" nature, says Chris Komelasky, CEO of SiteBridge Research.



Comments


bottom of page